Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Citing third-party data, Hettenback said downloads of the Hims & Hers apps increased 47% year over year in February. What it ...

Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...

Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

With the FDA shutting down its key revenue stream, Hims faces a tough road ahead--can it justify its valuation?

A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

"Hims," which advertises itself as an app for "hair loss, sexual health" and "Hers" which promotes "hair care, mental health." Morgan Stanley's research suggests the majority of downloads in ...